XTuit Pharmaceuticals, Inc. is a biopharmaceutical company developing novel microenvironment-activated therapeutics targeting key mechanisms resulting in hypoxia, decreased drug uptake, drug resistance, and decreased immune response.
Member count: 11-50
Total raised: $22M
Founded date: 2011
Investors 2
| Date | Name | Website |
| 06.07.2021 | New Enterp... | nea.com |
| - | Omega Fund... | omegafunds... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 11.06.2015 | Series A | $22M | - | medcitynew... |
Mentions in press and media 10
| Date | Title | Description | Category | Author | Source |
| 08.03.2017 | From Big P... | On Wednesday — international W... | - | - | medcitynew... |
| 08.03.2017 | Langer-bac... | Deborah Dunsire, M.D., has ach... | Biotech | - | fiercebiot... |
| 11.06.2015 | NEA joins ... | After spending the last four y... | Venture Ca... | - | fiercebiot... |
| 11.06.2015 | XTuit Phar... | This is XTuit’s official emerg... | - | - | medcitynew... |
| 11.06.2015 | XTuit Phar... | CAMBRIDGE, MA, XTuit Pharmac... | - | - | vcnewsdail... |
| 11.06.2015 | XTuit Rais... | XTuit Pharmaceuticals, Inc., a... | USA | - | finsmes.co... |
| 05.12.2014 | Harvard sp... | Our work has revealed that the... | - | - | medcitynew... |
| - | Harvard sp... | Polaris Partners-backed XTuit ... | - | - | medcitynew... |
| - | XTuit Phar... | Cambridge biotech XTuit Pharma... | - | - | medcitynew... |
| - | From Big P... | The human body has a tendency ... | - | - | medcitynew... |